Search Results - "Lynar, S"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Disseminated Saksenaea infection in an immunocompromised host associated with a good clinical outcome: a case report and review of the literature by Davidson, N, Campbell, K, Foroughi, F, Tayal, V, Lynar, S, Crawford, L. C, Kidd, S. E, Baird, R, Davies, J, Meumann, E. M

    Published in BMC infectious diseases (14-10-2020)
    “…Abstract Background Saksenaea species (spp.) are uncommon causes of mucormycosis but are emerging pathogens mostly associated with trauma and soil…”
    Get full text
    Journal Article
  2. 2

    Clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation (CASSETTE)-an open-labelled pilot randomized controlled trial by Campbell, A J, Dotel, R, Braddick, M, Britton, P N, Eisen, D P, Francis, J R, Lynar, S, McMullan, B, Meagher, N, Nelson, J, O'Sullivan, M V N, Price, D J, Robinson, J O, Whelan, A, Tong, S Y C, Bowen, A C, Davis, J S

    Published in JAC-antimicrobial resistance (01-02-2022)
    “…Combination antibiotic therapy with an antitoxin agent, such as clindamycin, is included in some guidelines for severe, toxin-mediated infections. The evidence…”
    Get full text
    Journal Article